Health

Volume 5, Issue 10 (October 2013)

ISSN Print: 1949-4998   ISSN Online: 1949-5005

Google-based Impact Factor: 0.74  Citations  

Prevalence of metabolic syndrome in type 2 diabetic patients: A comparative study using WHO, NCEP ATP III, IDF and Harmonized definitions

HTML  XML Download Download as PDF (Size: 238KB)  PP. 1689-1696  
DOI: 10.4236/health.2013.510227    5,994 Downloads   9,853 Views  Citations

ABSTRACT

To determine the prevalence of metabolic syndrome (MetS) in Malaysian type 2 diabetic patients using WHO, NCEP ATP III, IDF and the new Harmonized definitions, and the concordance between these definitions. This study involved 313 patients diagnosed with type 2 diabetes mellitus (T2DM) at two Malaysian tertiary hospitals. Socio-demographic data were assessed using a pre-tested interviewer-administered structured questionnaire. Anthropometric measurements were carried out according to standard protocols. Clinical and laboratory characteristics were examined. Kappa (k) statistics were used for the agreement between the four MetS definitions. The overall prevalence rates of MetS (95% CI) were 95.8% (93.6-98.1), 96.1% (94.0-98.3), 84.8% (80.8-88.9) and 97.7% (96.1-99.4) according to the WHO, NCEP ATP III, IDF and the Harmonized definitions, respectively. The Kappa statistics demonstrated a slight to substantial agreement between the definitions (k = 0.179-0.875, p < 0.001), where the WHO criteria revealed the highest concordance with the NCEP ATP III definition (k = 0.875, p < 0.001). The WHO against NCEP ATP III criteria evinced the highest sensitivity (99.66%) whereas Harmonized criteria against all the other three definitions showed the highest specificity (100%) in identifying MetS. In conclusion, the new Harmonized criteria established the highest prevalence of MetS among the four definitions applied. There was a very good concordance between the WHO and NCEP ATP III criteria. The extremely high prevalence of MetS observed in type 2 diabetic patients indicates an impending pandemic of CVD risk in Malaysia. Aggressive treatment of MetS components is required to reduce cardiovascular risk in T2DM.

Share and Cite:

Tan, M. C. , Ng, O. C. , Wong, T. W. , Joseph, A. , Chan, Y. M. and Hejar, A. R. (2013) Prevalence of metabolic syndrome in type 2 diabetic patients: A comparative study using WHO, NCEP ATP III, IDF and Harmonized definitions. Health, 5, 1689-1696. doi: 10.4236/health.2013.510227.

Cited by

[1] Determinants of metabolic syndrome among patients attending diabetes clinics in two sub-urban hospitals: Bono Region, Ghana
BMC …, 2022
[2] Prevalence of Metabolic Syndrome and Association with Physical Activity and Frailty Status in Spanish Older Adults with Decreased Functional Capacity: A Cross …
Perié, D Navarrete-Villanueva… - Nutrients, 2022
[3] Identification of Insulin Resistance Biomarkers in Metabolic Syndrome Detected by UHPLC-ESI-QTOF-MS
Hroub, M Mousa… - Metabolites, 2022
[4] Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast …
Diabetes & Metabolic Syndrome …, 2022
[5] Multiplatform metabolomics for an integrative exploration of metabolic syndrome in older men
2021
[6] Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis
2021
[7] Development of nonlaboratory-based risk prediction models for cardiovascular diseases using conventional and machine learning approaches
International Journal of …, 2021
[8] Реабилитация и эффективность санаторно-курортного лечения у больных с кардиометаболическими нарушениями
2020
[9] Prevalence of Metabolic Syndrome among Breast Cancer Survivors in East Coast of Peninsular Malaysia
2020
[10] Prévalences du syndrome métabolique et des facteurs de risque cardiovasculaire chez les diabétiques de type 2 vus au service d'endocrinologie …
2020
[11] Relationship of Metabolic Syndrome Defined by IDF or Revised NCEP with Glycemic Control among Malaysians with Type 2 Diabetes
2020
[12] The Impact of Metabolic Syndrome Defined by IDF or Revised NCEP on Glycemic control in Malaysians with Type 2 Diabetes
2020
[13] Metabolic syndrome among type 2 diabetic patients in Sub-Saharan African countries: a systematic review and meta-analysis
2020
[14] Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes
2020
[15] Prévalence du syndrome métabolique et des facteurs de risque cardiovasculaire chez les diabétiques de type 2 vu au service d'endocrinologie, Antananarivo
Pan African Medical …, 2020
[16] Prevalences of metabolic syndrome and cardiovascular risk factors in type 2 diabetics hospitalized in the Department of Endocrinology, Antananarivo
The Pan African …, 2020
[17] Prevalence of metabolic syndrome in diabetic patients attending a diabetic clinic in a tertiary care hospital
2019
[18] Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria
2019
[19] Metabolic syndrome among adults with type 2 diabetes in a Saudi teaching hospital: A comparative prevalence study using WHO and ATP III definitions
2019
[20] The mediating role of metabolic syndrome in cardiovascular diseases
2019
[21] Prevalence of metabolic syndrome in diabetic patients attending a diabetic clinic in a tertiary care hospital.
2019
[22] Metabolic syndrome associates with Ischemic heart disease: cross sectional study in Al-Hussein teaching hospital
2019
[23] Objectively Measured Physical Activity, Sedentary Behavior, and Metabolic Syndrome in Adults: Systematic Review of Observational Evidence
2018
[24] Elevated liver transaminases and their association with metabolic syndrome in type 2 diabetic patients attending tertiary care hospital of Nepal
Clinical Lipidology, 2018
[25] The Prevalence of Metabolic Syndrome and Its Components among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital, Northwest Ethiopia
2018
[26] Evaluation of anti diabetic function of gymnena sylvestre in subjects with type II diabetes mellitus and metabolic syndrome Elucidation of molecular mechanism
2018
[27] The Prevalence of Metabolic Syndrome and Its Components among Type Diabetes Mellitus Patients at the University of Gondar Hospital, Northwest Ethiopia
2018
[28] ASSOCIATION OF GENETIC POLYMORPHISMS OF DIPEPTIDYL PEPTIDASE-4 WITH TYPE 2 DIABETES MELLITUS IN MALAYSIAN SUBJECTS
2017
[29] ALAD
2017
[30] Association of genetic polymorphisms of dipeptidyl peptidase-4 with Type 2 Diabetes Mellitus in Malaysian subjects/Radwan Hamoud Ali Ahmed
2017
[31] Biochemical studies and genetic polymorphism involved in Diabetes in North Indian Population
2017
[32] Higher body mass index and lower intake of dairy products predict poor glycaemic control among Type 2 Diabetes patients in Malaysia
PLOS ONE, 2017
[33] Prevalence of Metabolic Syndrome in individuals with Type 2 Diabetes Mellitus
2017
[34] Prevalência da Síndrome Metabólica em pessoas com Diabetes Mellitus tipo 2
Revista Brasileira de Enfermagem, 2017
[35] Diabetic foot ulcer mobile detection system using smart phone thermal camera: a feasibility study
2017
[36] PO317 ARE THERE ANY CORRELATIONS BETWEEN RATIO LDL-C/HDL-C AND LIPOPROTEIN (A) WITH INSULIN RESISTANCE IN TYPE 2 DIABETES …
2014
[37] Current clinical status and vascular complications among patients with type 2 Diabetes mellitus at tertiary hospitals in Malaysia.
British Journal of …, 2014
[38] Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria
Journal of Diabetes & Metabolic Disorders, 2014
[39] Current clinical status and vascular complications among patients with type 2 diabetes mellitus at tertiary hospitals in Malaysia
British Journal of Medicine and Medical Research, 2014
[40] PO317 ARE THERE ANY CORRELATIONS BETWEEN RATIO LDL-C/HDL-C AND LIPOPROTEIN (A) WITH INSULIN RESISTANCE IN TYPE 2 DIABETES PATIENTS WITH ABDOMINAL OBESITY?
Diabetes Research and Clinical Practice, 2014
[41] PO317 ARE THERE ANY CORRELATIONS BETWEEN RATIO LDL-C/HDL-C AND LIPOPROTEIN (A) WITH INSULIN RESISTANCE IN TYPE 2 DIABETES PATIENTS …
2014
[42] Are There Any Correlations Between Ratio LDL-C/HDL-C and Lipoprotein (A) With Insulin Resistance in Type 2 Diabetes Patients With Abdominal Obesity?
Diabetes Research …, 2014
[43] Metabolic syndrome among patients with type 2 diabetes in Jordan: A cross-sectional study
Refai, N Layyous

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.